News

• August 5, 2022
  

  PRO Consortium Announces Publication of Open Access Article

  C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures” was published by Quality of Life Research on July 19, 2022. The article presents the data collected by three PRO Consortium working groups to identify...
• July 25, 2022
  

  Diary for Irritable Bowel Syndrome Symptoms-Constipation Now Available for Licensing

  C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) is available for licensing via FACIT.org. Information on the DIBSS–C and all of the PRO Consortium’s qualified measures, including item content and available translations, can be found online. Access here:   https://www.c-pathcoas.org/
• July 15, 2022
  

  eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials

  C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impaired” has been published in Applied Clinical Trials. The article examines how even complex cognitive assessments can be administered remotely using established electronic data collection methods. Access here:  https://www.appliedclinicaltrialsonline.com/view/administering-complex-cognitive-tests-remotely-in-the-cognitively-impaired
• June 28, 2022
  

  C-Path Welcomes RWS

    C-Path is proud to welcome RWS as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Comprised of 19 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, eCOA Consortium members collaborate in a pre-competitive environment to support and...
• June 28, 2022
  

  C-Path Welcomes Parexel

  C-Path is proud to welcome Parexel as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Comprised of 17 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, eCOA Consortium members collaborate in a pre-competitive environment to support and conduct novel research, design...